FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity
Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's resubmission of its Supplemental Biologics ...
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Botox (a.k.a. Botulinum toxin type A), known as a neuromodulator, “is a protein that is extracted from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback